Sinclair Broadcast Group Inc, Emerson Electric Co, EXXON MOBIL CORPORATION, CENTENE CORPORATION, McDonald's Corp, Wipro Ltd are all expected to be Up Before their earnings are released Wednesday. Symbol Company# of Reports Quarter Release Date. SBGI Sinclair Broadcast Group Inc November Earnings Q3 11/04/2015.
BUYINS.NET/ www.squeezetrigger.com is monitoring the Seasonality of CENTENE CORPORATION, AVIVA PLC- SPON ADR, LHC GROUP, INC., TAL International Group Inc, Koppers Holdings Inc, EXCO Resources Inc and each have a high seasonal probability to go Up in the next weeks. CNC CENTENE CORPORATION 4.69% 84.62% Tuesday, October 20th 2015. AV AVIVA PLC- SPON
Biologics, Inc., is pleased to announce that it has been selected by Taiho Oncology, Inc. as a specialty pharmacy provider for LONSURF . LONSURF was approved by the U.S. Food and Drug Administration on September 22, 2015, for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxali
Research and Markets has announced the addition of the " UK Retail Pharmacies Market Update 2015" report to their offering. This market update examines the pharmacies sector in the UK. The vast majority of pharmacies/dispensing chemists in the UK have an NHS dispensing contract.
Dublin- Research and Markets has announced the addition of the " UK Retail Pharmacies Market Update 2015" report to their offering. This market update examines the pharmacies sector in the UK. The vast majority of pharmacies/dispensing chemists in the UK have an NHS dispensing contract.
US demand for pharmaceutical chemicals is forecast to rise 6.1 percent annually to $54 billion in 2019. Although moderated by patent losses, the value of pharmaceutical chemicals obtained from captive and contract production systems will sustain favorable growth, expanding 5.3 percent annually to $36.7 billion in 2019. For example, in 2014, a total
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, is pleased to announce that it has listed multiple products in Provincial formularies of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec. Each Province maintains the formulary autonomously and decides regardin
Allergan plc and Medicines 360 today announced that LILETTA will be featured in 3 abstracts presenting new data at the FIGO World Congress of Gynecology and Obstetrics, which takes place from October 4-9, 2015 in Vancouver, Canada. The scheduled times and titles of the presentations are as follows: Presentation Date: Tuesday, October 6 th, Pre
Boston Therapeutics, Inc. today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd., completed enrollment for the clinical trial at The Chinese University of Hong Kong to evaluate BTI-320 in subjects who are pre-diabetic. This key developmental trial, being conducted in Hong Kong and the associated endpoints are pivotal for
Bristol-Myers Squibb will pay $14.6 million to settle charges from U.S. regulators that its joint venture in China gave cash and other benefits to government health care providers to boost drug sales. Bristol-Myers Squibb, based in New York, makes and sells prescription and over-the-counter medicines worldwide. Bristol-Myers Squibb was the lates
Flamel Technologies announced today that the Company's Irish subsidiary, Flamel Ireland Limited, has licensed exclusive U.S. rights to the LiquiTime drug delivery platform to Perrigo's Irish subsidiary, Elan Pharma International Limited, for the U.S. LiquiTime is Flamel's drug delivery platform for modified, extended and controlled release of
Release date- 02102015- Paris, France- Ipsen today announced that, in collaboration with the U.S. Ipsen markets the orphan drug, which is considered to be a drug of medical necessity, in the United States and most European countries. On 25 April 2013, Ipsen announced that the supplier of Increlex's active ingredient, Lonza Biologics Inc, was facing
DUBLIN and LOUISVILLE, Ky., Oct. 2, 2015/ PRNewswire/ Allergan plc, a leading global specialty pharmaceutical company, today announced a multi-year research collaboration with Humana Inc., one of the nation's leading health and well-being companies, to explore new ideas and ways to improve the health and well-being of patients, members and their
Allergan, plc is pleased to announce that KYBELLA injection, the first and only FDA- approved injectable treatment for improving the appearance of moderate to severe submental fullness, also known as "double chin," received a "2015 Breakthrough Award" from Allure Magazine. The publication honored KYBELLA , along with other winners from their
For those on Medicare, this month can be critical. Those who ignore the open enrollment season, which runs Oct. 15 through Dec. 7, could wind up paying hundreds of dollars in unnecessary prescription drug charges next year, especially as some drug prices have soared in recent months, say Medicare experts. It's also a potentially treacherous period,
International Business Systems, a leading global integrated ERP and supply chain provider, today announced Sunset Pharmaceuticals, a primary wholesaler of pharmaceutical and medical supplies, has selected IBS Enterprise to support its business expansion in small-to-medium-size medical surgery markets. Sunset Pharmaceuticals is a rapidly growing..